ATS is pleased to announce Beta-release of a wide array of targeted toxins for use in eliminating specific cell types. This Beta-Testing Program will make new conjugates available to our customers sooner.
Each of the Beta products will have:
- Saporin activity confirmed,
- Peptide sequences published/confirmed, and/or
- Antibody binding specificity published/confirmed.
Beta Products have not been characterized or reported in scientific literature. This provides researchers with special Beta-pricing ($50 for 25 micrograms) and the opportunity to be the first to publish using the material. The researcher who first publishes data will receive a $500 credit for use on ATS products.
Data submitted will be reviewed by the scientific team at ATS. If data is sufficient to prove specific activity of Beta material in either in vivo or in vitro conditions, the Beta Tester will be informed and product credit will be awarded to the first Beta Tester to publish.
Check the website for a current list of Beta-Test Products, and check back each quarter as new products are released in Targeting Trends.